Skip to content
10-Q

Quarterly Report

CEREVEL THERAPEUTICS HOLDINGS, INC.

0000950170-23-057422

← back to feed
Filed
Nov 1, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 27, 2023 180.28M sh
Shares Diluted Q3 2023 · Sep 30, 2023 157.5M sh
Shares Diluted Q3 2023 · Sep 30, 2023 157.07M sh
Shares Diluted Q3 2023 · Sep 30, 2022 152.3M sh
Shares Diluted Q3 2023 · Sep 30, 2022 149.54M sh
Capex Q3 2023 · Sep 30, 2023 $2.91M
Capex Q3 2023 · Sep 30, 2022 $3.5M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$244.88M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$205.71M
Long Term Debt Q3 2023 · Sep 30, 2023 $379.5M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $155.72M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $136.52M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $248.6M
Stockholders Equity Q3 2023 · Sep 30, 2023 $272.96M
Stockholders Equity Q3 2023 · Jun 30, 2023 $350.5M
Stockholders Equity Q3 2023 · Mar 31, 2023 $431.71M
Stockholders Equity Q3 2023 · Dec 31, 2022 $521.24M
Stockholders Equity Q3 2023 · Sep 30, 2022 $603.36M
Stockholders Equity Q3 2023 · Jun 30, 2022 $452.81M
Stockholders Equity Q3 2023 · Mar 31, 2022 $521.5M
Stockholders Equity Q3 2023 · Dec 31, 2021 $578.73M
Current Liabilities Q3 2023 · Sep 30, 2023 $78.84M
Current Liabilities Q3 2023 · Dec 31, 2022 $72.56M
Total Liabilities Q3 2023 · Sep 30, 2023 $549M
Total Liabilities Q3 2023 · Dec 31, 2022 $496.58M
Current Assets Q3 2023 · Sep 30, 2023 $687.79M
Current Assets Q3 2023 · Dec 31, 2022 $905.65M
Total Assets Q3 2023 · Sep 30, 2023 $821.96M
Total Assets Q3 2023 · Dec 31, 2022 $1.02B
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.61
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.91
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.66
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.73
Eps Basic Q3 2023 · Sep 30, 2023 −$0.61
Eps Basic Q3 2023 · Sep 30, 2023 −$1.91
Eps Basic Q3 2023 · Sep 30, 2022 −$0.66
Eps Basic Q3 2023 · Sep 30, 2022 −$1.73
Sga Expense Q3 2023 · Sep 30, 2023 $26.06M
Sga Expense Q3 2023 · Sep 30, 2023 $70.19M
Sga Expense Q3 2023 · Sep 30, 2022 $23.68M
Sga Expense Q3 2023 · Sep 30, 2022 $61.65M
Rd Expense Q3 2023 · Sep 30, 2023 $85.25M
Rd Expense Q3 2023 · Sep 30, 2023 $237.51M
Rd Expense Q3 2023 · Sep 30, 2022 $71.39M
Rd Expense Q3 2023 · Sep 30, 2022 $198.95M
Net Income Q3 2023 · Sep 30, 2023 −$96.36M
Net Income Q3 2023 · Sep 30, 2023 −$300.18M
Net Income Q3 2023 · Jun 30, 2023 −$99.54M
Net Income Q3 2023 · Mar 31, 2023 −$104.29M
Net Income Q3 2023 · Sep 30, 2022 −$99.94M
Net Income Q3 2023 · Sep 30, 2022 −$258.7M
Net Income Q3 2023 · Jun 30, 2022 −$90.47M
Net Income Q3 2023 · Mar 31, 2022 −$68.29M
Operating Income Q3 2023 · Sep 30, 2023 −$111.31M
Operating Income Q3 2023 · Sep 30, 2023 −$307.7M
Operating Income Q3 2023 · Sep 30, 2022 −$95.07M
Operating Income Q3 2023 · Sep 30, 2022 −$260.6M